gbfi

Frost & Sullivan recognized Reagena as ’European zoonotic point-of-care diagnostic company of the year 2020’

 

Year 2020 award was earned by Reagena’s pioneering leadership in further advancing rapid diagnostics in the zoonotic point-of-care diagnostics market. The award was continuation of previous Frost & Sullivan recognitions for Reagena’s efforts in Hantavirus and TBE rapid POCT to enhance customer value and enable effective clinical management.

Here is Analyst Quotes

Reagena-Oy-Award-Logo.jpg